LT

Lida Tehrani

SP Signal Pharmaceuticals: 13 patents #20 of 207Top 10%
Merck: 7 patents #1,604 of 9,382Top 20%
BS Bristol-Myers Squibb: 5 patents #1,010 of 3,969Top 30%
📍 San Diego, CA: #1,604 of 23,606 inventorsTop 7%
🗺 California: #21,822 of 386,348 inventorsTop 6%
Overall (All Time): #157,762 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
12227490 Cereblon binding compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more 2025-02-18
12103920 Cereblon binding compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more 2024-10-01
11739075 Cereblon binding compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more 2023-08-29
11634407 Cereblon binding compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more 2023-04-25
11560371 Cereblon binding compounds, compositions thereof, and methods of treatment therewith Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more 2023-01-24
11292796 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2022-04-05
10683298 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2020-06-16
10167290 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2019-01-01
9795607 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2017-10-24
9771371 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2017-09-26
9428509 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2016-08-30
9346812 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2016-05-24
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-07-23
8372976 Methods of treatment comprising the administration of heteroaryl compounds Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2013-02-12
8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Sogole Bahmanyar, R.J. Bates, Kate Blease, Andrew Antony Calabrese, Thomas Oran Daniel +22 more 2012-10-30
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2012-02-07
7981893 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2011-07-19
7910561 Inhibitors of Akt activity Jeannie M. Arruda, Brian T. Campbell, Nicholas D. P. Cosford, Jacob M. Hoffman, Essa Hu +8 more 2011-03-22
7750151 Inhibitors of Akt activity Mark T. Bilodeau, Chixu Chen, Nicholas D. P. Cosford, Brian Walter Eastman, John C. Hartnett +4 more 2010-07-06
7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds Nicholas David Peter COSFORD, Jeffrey Roger Roppe, Nicholas D. Smith, Brian Andrew Stearns, Dehua Huang +2 more 2008-12-09
7393959 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 Nicholas David Peter COSFORD, Dehua Huang, Jeffrey Roger Roppe, Nicholas D. Smith 2008-07-01
7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds Nicholas David Peter COSFORD, Jeffrey Roger Roppe, Nicholas D. Smith, Brian Andrew Stearns, Dehua Huang +1 more 2008-04-29
7268151 Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 Nicholas David Peter COSFORD, Jeffrey Roger Roppe, Bowei Wang 2007-09-11
7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 Nicholas David Peter COSFORD, Petpiboon Prasit, Jeffrey Roger Roppe, Nicholas D. Smith 2006-09-12